Conditional Economic Incentives for HIV Treatment Adherence: Aligning Adolescent Developmental Hallmarks with Behavioral Economic Theory to Improve HIV Treatment Adherence.

Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9607225 Publication Model: Print Cited Medium: Internet ISSN: 1557-7449 (Electronic) Linking ISSN: 10872914 NLM ISO Abbreviation: AIDS Patient Care STDS Subsets: MEDLINE

Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c1996-

HIV Infections*/drug therapy ; Motivation*; Adolescent ; Anti-Retroviral Agents/therapeutic use ; Economics, Behavioral ; Humans ; Medication Adherence

Adolescent-tailored antiretroviral therapy (ART) adherence interventions take place within the context of unique developmental stage. Suboptimal ART adherence among adolescents living with HIV in South Africa underscores that interventions are urgently needed to improve adherence. We conducted semistructured in-depth interviews with 35 adolescents aged 10-19 years living with HIV. In addition, 14 clinicians and 35 caregivers were interviewed to provide a diverse perspective on barriers and facilitators of medication adherence for adolescents living with HIV (ALWH). Thematic coding was utilized for this analysis. Our main findings were organized by following a priori themes: (1) acceptability of conditional economic incentives (CEIs) as an adherence intervention strategy for adolescents, (2) predicted behavioral impacts, and the (3) durability of CEIs to ensure medication adherence for adolescents in the long term. Subthemes that emerged included CEIs as tool to overcome competing demands, increasing intrinsic motivation and orientation toward the future, and optimal timing of the intervention. Exposure to a CEI intervention during early adolescence (ages 10-13) may be a particularly helpful intervention as CEIs may have long-lasting effects given that habit-formation behavior is developed during early adolescence. There is little consensus on effect duration from the perspective of adolescents, clinicians, and caregivers. Future studies should continue to explore the impact of CEIs for long-term ART adherence.

AIDS Patient Care STDS. 2009 Oct;23(10):799-801. (PMID: 19803676)
AIDS. 2014 Aug 24;28(13):1945-56. (PMID: 24845154)
J Behav Med. 2017 Oct;40(5):832-838. (PMID: 28508382)
Prev Med. 2012 Nov;55 Suppl:S7-S16. (PMID: 22198622)
Soc Sci Med. 2020 Nov;265:113333. (PMID: 32896799)
AIDS Patient Care STDS. 2014 Jan;28(1):28-32. (PMID: 24428797)
Trop Med Int Health. 2015 Aug;20(8):1015-32. (PMID: 25877007)
Curr Opin HIV AIDS. 2013 Jan;8(1):59-64. (PMID: 23211779)
PLoS Med. 2013;10(4):e1001418. (PMID: 23585736)
AIDS Care. 2015;27(7):805-16. (PMID: 25702789)
Clin Infect Dis. 2014 Apr;58(7):1003-11. (PMID: 24429438)
N Engl J Med. 2015 Aug 27;373(9):795-807. (PMID: 26192873)
Arch Pediatr Adolesc Med. 2003 Mar;157(3):249-55. (PMID: 12622674)
AIDS Behav. 2011 Oct;15(7):1381-96. (PMID: 21468660)
Dev Rev. 2008 Mar;28(1):78-106. (PMID: 18509515)
J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71. (PMID: 19282780)
J Int AIDS Soc. 2015 Sep 16;18:20049. (PMID: 26385853)
N Engl J Med. 2011 Aug 11;365(6):493-505. (PMID: 21767103)
Curr HIV/AIDS Rep. 2010 Feb;7(1):44-51. (PMID: 20425057)
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD009513. (PMID: 22161452)
Clin Infect Dis. 2014 Jul;59 Suppl 1:S21-7. (PMID: 24926028)
Health Psychol. 2013 Sep;32(9):932-40. (PMID: 24001243)
Ann Intern Med. 2000 Jul 4;133(1):21-30. (PMID: 10877736)

P2C HD041020 United States HD NICHD NIH HHS; R21 AI118393 United States AI NIAID NIH HHS

Keywords: HIV; adolescents; conditional economic incentives; qualitative

0 (Anti-Retroviral Agents)

Date Created: 20220707 Date Completed: 20220711 Latest Revision: 20230703

20240105

PMC9298493

10.1089/apc.2022.0060

35797651